b'ADVERTISING GUIDEFerring GenmabAt Ferring, we are committed to helping peopleGenmab is an international biotechnology build families and live better lives. In thecompany with a core purpose of guiding its United States, Ferring is a leader in reproductiveunstoppable team to strive toward improvingmedicine and maternal health, uro-oncologythe lives of patientsand in specialty areas within orthopedicswith innovative andand gastroenterology including microbiomedifferentiated antibodytherapeutics. therapeutics. For 25 years, its passionate, innovative and collaborative team has invented Ferring develops life- next-generation antibody technology platforms changing therapies toand leveraged translational, quantitative and address the unmet medical needs of patientsdata sciences, resulting in a proprietary pipeline diagnosed with bladder and other urologicalincluding bispecific T-cell engagers, antibody-cancers. We offer a novel, first-in-classdrug conjugates, next-generation immune intravesical gene therapy for non-muscle invasivecheckpoint modulators and effector function-bladder cancer that provides patients with anenhanced antibodies. By 2030, Genmabs vision alternative to bladder removal surgery. is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO) antibody medicines. See our ad on page 75. Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X. See our ad on page 6.ADVERTISING GUIDETHEDIRECTORY'